Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2081947 | Drug Discovery Today: Disease Mechanisms | 2007 | 8 Pages |
Abstract
Renal fibrosis is the hallmark of chronic kidney disease (CKD) leading to organ failure and the need for renal replacement therapy. An increasing body of evidence suggests that tissue hypoxia, which is sustained, among other things, by progressive microvascular loss, plays an important role in the pathogenesis of ongoing renal fibrosis via direct and indirect mechanisms. Therapeutic strategies that target chronic hypoxia may be of benefit in ameliorating this intractable disease.
Section editor:Michael S. Goligorsky – Renal Research Institute, New York Medical College, Valhalla, NY, USA
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Jill T. Norman, Leon G. Fine,